Sun Pharma Inds. - Quaterly Results
Date: 22-05-2024
The sales declined to Rs. 56391.40 millions for the March 2024 quarter as compared to Rs. 59482.20 millions during the corresponding quarter last year.The Total Profit for the quarter ended March 2024 of Rs. 8676.00 millions grew from Rs.-10208.20 millionsThe Operating Profit of the company witnessed a decrease to 20124.10 millions from 24809.50 millions.
| | Quarter ended | Year to Date | Year ended |
| | 202403 | 202303 | % Var | 202403 | 202303 | % Var | 202403 | 202303 | % Var |
| Sales | 56391.40 | 59482.20 | -5.20 | 202751.70 | 208121.40 | -2.58 | 202751.70 | 208121.40 | -2.58 |
| Other Income | 1188.80 | 1203.00 | -1.18 | 5534.80 | 3292.90 | 68.08 | 5534.80 | 3292.90 | 68.08 |
| PBIDT | 20124.10 | 24809.50 | -18.89 | 60533.70 | 67518.90 | -10.35 | 60533.70 | 67518.90 | -10.35 |
| Interest | 2175.90 | 1614.50 | 34.77 | 7840.80 | 4721.80 | 66.06 | 7840.80 | 4721.80 | 66.06 |
| PBDT | 17948.20 | -6182.90 | -390.29 | 50502.70 | 33419.20 | 51.12 | 50502.70 | 33419.20 | 51.12 |
| Depreciation | 3930.40 | 4119.80 | -4.60 | 16006.20 | 16008.70 | -0.02 | 16006.20 | 16008.70 | -0.02 |
| PBT | 14017.80 | -10302.70 | -236.06 | 34496.50 | 17410.50 | 98.14 | 34496.50 | 17410.50 | 98.14 |
| TAX | 5341.80 | -94.50 | -5752.70 | 5914.70 | 503.30 | 1075.18 | 5914.70 | 503.30 | 1075.18 |
| Deferred Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PAT | 8676.00 | -10208.20 | -184.99 | 28581.80 | 16907.20 | 69.05 | 28581.80 | 16907.20 | 69.05 |
| Equity | 2399.30 | 2399.30 | 0.00 | 2399.30 | 2399.30 | 0.00 | 2399.30 | 2399.30 | 0.00 |
| PBIDTM(%) | 35.69 | 41.71 | -14.44 | 29.86 | 32.44 | -7.97 | 29.86 | 32.44 | -7.97 |